Redsense Medical AB

REDS

SE0006965158

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-05-23 EDT			5-day change	1st Jan Change
7.5 ^SEK	+5.63%		+20.58%	-1.32%

05-08	Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-27	Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Redsense Medical AB Receives Order from One of the Company's US Distributors

October 18, 2022 at 08:43 am

Redsense Medical AB (publ) has secured its largest single order to date, valued at SEK 3.7 Million, from one of the company's US distributors.

Latest news about Redsense Medical AB

Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-27	CI
Redsense Medical Late Board Chair's Company to Retain Shares	02-06	MT
Redsense Medical Appoints Eva Walde as Chairman of Board of Directors	01-08	CI
Redsense Medical Announces Demise of Patrik Byhmer as Chairman of the Board	12-23	CI
Redsense Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Redsense Medical AB Announces Nomination Committee Appointed for the 2024 Annual General Meeting	23-10-26	CI
Redsense Medical to Start Trading on US OTCQX Platform	23-09-29	MT
Redsense Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Redsense Medical AB Secures New Order of SEK 11.2 Million	23-08-15	CI
Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-27	CI
Redsense Medical AB Announces Appointment of Jennie Kardell as Chief Financial Officer, Effective March 2023	23-01-20	CI
Redsense Medical Announces Partial Delivery of Record Order	23-01-03	CI
Redsense Medical Secures New Order Valued at SEK 15.2 Million from One of the Company's US Distributors	22-12-02	CI
Redsense Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-15	CI
Redsense Medical AB Receives Order from One of the Company's US Distributors	22-10-18	CI
Redsense Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI
Redsense Medical AB Appoints Patrik Byhmer as Chairman of the Board	22-07-06	CI
Redsense Medical Announces CEO Changes	22-07-06	CI
Redsense Medical AB Announces CEO Changes	22-05-02	CI
Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-02	CI
Redsense Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-28	CI
Redsense Medical AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-28	CI
Redsense Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI

Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
REDSENSE MEDICAL AB	-1.32%	9.89M
BIOMÉRIEUX	-4.92%	12.27B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.82%	7.99B
DIASORIN S.P.A.	+5.43%	5.69B
LANTHEUS HOLDINGS, INC.	+26.16%	5.42B
AUTOBIO DIAGNOSTICS CO., LTD.	-9.58%	4.13B
10X GENOMICS, INC.	-59.63%	2.7B
ANDON HEALTH CO., LTD.	+8.44%	2.6B
VITROLIFE AB	-3.70%	2.38B
MYRIAD GENETICS, INC.	+21.00%	2.1B

Diagnostic & Testing Substances